Maggie Hassan actually said...

"In light of this safeness conception, do you think calling these products 'abuse deterrent' is misleading or causing providers to think that these products are less addictive?"

"I commend the FDA for putting out its Opioid Action Plan last year, but I want to be very clear that there is still much more work that the FDA needs to do on this issue."

"I hear from constituents all the time who, because of the Affordable Care Act for the first time, got access to lifesaving treatment."

"Thank you for being here today on this really important topic."